Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Stomatitis 9Neoplasms 6Head and Neck Neoplasms 4Multiple Myeloma 2Mucositis 2Leukemia 2Xerostomia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Oral Ulcer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Laryngeal Diseases 1Hematologic Neoplasms 1Graft vs Host Disease 1Deglutition Disorders 1Colonic Neoplasms 1Cataract 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Lenalidomide 1Fibroblast Growth Factor 7 1Denosumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cataract × Fibroblast Growth Factor 7 × Clear all
NCT00434161 2015-03-30

A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Multiple Myeloma

Swedish Orphan Biovitrum

Phase 3 Completed
281 enrolled 27 charts
Plasma cell

Cataract, Multiple Myeloma, Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡